Divi’s Laboratories Ltd Net Profit is INR 470.62 crores in Q3 FY 2020-2021

Divi’s Laboratories Ltd Q3 FY20-21 Quarter Result

Divi’s Laboratories Ltd Net Profit is INR 470.62 crores in Quarter 3, October – December of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Divi’s Laboratories Ltd Quarter Net Profit is Up by 31 % from Last Year Quarter and Net Profit of INR 470.62 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 359.09 crores.

Quarterly Net Sales Year-on-Year

Divi’s Laboratories Ltd Quarter Sale is up 22 % from Last Quarter. Sales of 1701.44 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 1396.26

Annual Sales & Net Earning

Divi’s Laboratories Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 4946.26 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 1352.74 crores.


Divi’s Laboratories Ltd Stock Information

SectorPharmaceuticals
IndustryPharmaceuticals – Indian – Bulk Drugs
AboutDivis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its Custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.(
Latest Qaurter EPS17.72789788403024

Divi’s Laboratories Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Divi’s Laboratories Ltd

Leave a Comment

Your email address will not be published. Required fields are marked *